2 completed, 1 terminated, 1 withdrawn. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow Coagulation: new trials by email Literature Review of Coagulation trials Research Report on Coagulation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Targeted Anticoagulation Therapy to Reduce Inflammation and Cellular Activation in Long-term HIV Disease Edoxaban 30mg daily, Matching placebo - Inflammation, Coagulation | Phase 2 | Completed | Hennepin Healthcare Research Institute | 44 | 2015-07-01 | 2019-09-06 |
| Hemostatic Closure of Femoral Artery Access Site, Using the QuickClose Design 9 System closure device - Coagulation, Therapeutic Uses | Phase 1 / Phase 2 | Withdrawn | CardioDex | 50 | 2010-05-01 | 2010-09-29 |
| Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA) TTP889, Placebo - Coagulation | Phase 2 | Terminated | vTv Therapeutics | 2 | 2009-06-01 | 2011-06-27 |
| Effectiveness of Plasma Transfusions in Critical Care Patients Frozen Plasma - Coagulation | Phase 1 / Phase 2 | Completed | Ottawa Hospital Research Institute | 70 | 2005-04-01 | 2008-10-21 |
Thrombosis (4) · HIV Infections (1) · Heart Diseases (1) · Heart Failure (1) · Inflammation (1) · Wounds and Injuries (1)
Cardiovascular Diseases (4) · Embolism and Thrombosis (4) · Vascular Diseases (4) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · RNA Virus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1)
Vascular Closure Devices (1) · edoxaban (1)
CardioDex (1) · Hennepin Healthcare Research Institute (1) · Ottawa Hospital Research Institute (1) · vTv Therapeutics (1)
United States (2) · Canada (1) · Israel (1)
Alan Moskowitz, MD (1) · Alan Tinmouth, MD (1) · Jason Baker, M.D. (1) · Yoshifumi Naka, MD, PhD (1)